D C Harrison, P J Meffin, R A Winkle. Show Affiliations »
Abstract
Mesh: See more » Anilides/metabolismAnilides/therapeutic useAnti-Arrhythmia Agents/metabolismAnti-Arrhythmia Agents/therapeutic useAprindine/metabolismAprindine/therapeutic useBiological AvailabilityDisopyramide/metabolismDisopyramide/therapeutic useHalf-LifeHumansLidocaine/metabolismLidocaine/therapeutic useMexiletine/metabolismMexiletine/therapeutic usePhenytoin/metabolismPhenytoin/therapeutic useProcainamide/metabolismProcainamide/therapeutic usePropranolol/metabolismPropranolol/therapeutic useQuinidine/metabolismQuinidine/therapeutic use
Substances: See more » AnilidesAnti-Arrhythmia AgentsMexiletineAprindinePhenytoinLidocainePropranololDisopyramideQuinidineProcainamide
Year: 1977 PMID: 335439 DOI: 10.1016/0033-0620(77)90022-6
Source DB: PubMed Journal: Prog Cardiovasc Dis ISSN: 0033-0620 Impact factor: 8.194